{"name": "MacroGenics",
 "permalink": "macrogenics",
 "crunchbase_url": "http://www.crunchbase.com/company/macrogenics",
 "homepage_url": "http://www.macrogenics.com",
 "blog_url": "http://www.macrogenics.com/news.html",
 "blog_feed_url": "",
 "twitter_username": "MacroGenics",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "info@macrogenics.com",
 "phone_number": "301-251-5172",
 "description": "",
 "created_at": "Fri Jun 19 03:20:26 UTC 2009",
 "updated_at": "Thu Apr 18 06:52:33 UTC 2013",
 "overview": "\u003Cp\u003EMacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company\u00e2\u20ac\u2122s Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       95],
      "assets/images/resized/0005/9708/59708v1-max-150x150.jpg"],
     [[188,
       120],
      "assets/images/resized/0005/9708/59708v1-max-250x250.jpg"],
     [[188,
       120],
      "assets/images/resized/0005/9708/59708v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co-founder ",
    "person":
     {"first_name": "Jeffrey",
      "last_name": "V. Ravetch",
      "permalink": "jeffrey-v-ravetch",
      "image": null}},
   {"is_past": false,
    "title": "President and Chief Executive Officer",
    "person":
     {"first_name": "Scott",
      "last_name": "Koenig",
      "permalink": "scott-koenig",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Chief Financial Officer",
    "person":
     {"first_name": "James",
      "last_name": "Karrels",
      "permalink": "james-karrels",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice President, Research",
    "person":
     {"first_name": "Ezio",
      "last_name": "Bonvini",
      "permalink": "ezio-bonvini",
      "image": null}}],
 "competitions":
  [{"competitor":
     {"name": "LigoCyte Pharmaceuticals",
      "permalink": "ligocyte-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            72],
           "assets/images/resized/0004/9543/49543v1-max-150x150.png"],
          [[249,
            120],
           "assets/images/resized/0004/9543/49543v1-max-250x250.png"],
          [[249,
            120],
           "assets/images/resized/0004/9543/49543v1-max-450x450.png"]],
        "attribution": null}}}],
 "providerships":
  [],
 "total_money_raised": "$45M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://macrogenics.com/press_releases-244.html",
    "source_description": "MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs",
    "raised_amount": 45000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 5,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Ventures West",
         "permalink": "ventures-west",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0001/0785/10785v1-max-150x150.png"],
             [[240,
               74],
              "assets/images/resized/0001/0785/10785v1-max-250x250.png"],
             [[240,
               74],
              "assets/images/resized/0001/0785/10785v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Caisse de Depot et Placement du Quebec",
         "permalink": "caisse-de-depot-et-placement-du-quebec",
         "image":
          {"available_sizes":
            [[[150,
               37],
              "assets/images/resized/0010/0614/100614v2-max-150x150.png"],
             [[249,
               62],
              "assets/images/resized/0010/0614/100614v2-max-250x250.png"],
             [[249,
               62],
              "assets/images/resized/0010/0614/100614v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "RiverVest",
         "permalink": "rivervest",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0005/2715/52715v1-max-150x150.jpg"],
             [[210,
               57],
              "assets/images/resized/0005/2715/52715v1-max-250x250.jpg"],
             [[210,
               57],
              "assets/images/resized/0005/2715/52715v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Biogen Idec New Ventures",
         "permalink": "biogen-idec-new-ventures",
         "image":
          {"available_sizes":
            [[[143,
               61],
              "assets/images/resized/0006/4829/64829v1-max-150x150.png"],
             [[143,
               61],
              "assets/images/resized/0006/4829/64829v1-max-250x250.png"],
             [[143,
               61],
              "assets/images/resized/0006/4829/64829v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Texas Pacific Group",
         "permalink": "texas-pacific-group",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0006/1517/61517v3-max-150x150.jpg"],
             [[250,
               78],
              "assets/images/resized/0006/1517/61517v3-max-250x250.jpg"],
             [[336,
               105],
              "assets/images/resized/0006/1517/61517v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "InterWest Partners",
         "permalink": "interwest-partners",
         "image":
          {"available_sizes":
            [[[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-150x150.png"],
             [[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-250x250.png"],
             [[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MPM Capital",
         "permalink": "mpm-capital",
         "image":
          {"available_sizes":
            [[[150,
               142],
              "assets/images/resized/0004/5561/45561v1-max-150x150.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-250x250.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mithra Ventures",
         "permalink": "mithra-ventures",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Red Abbey Venture Partners",
         "permalink": "red-abbey-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               98],
              "assets/images/resized/0004/6604/46604v1-max-150x150.jpg"],
             [[175,
               115],
              "assets/images/resized/0004/6604/46604v1-max-250x250.jpg"],
             [[175,
               115],
              "assets/images/resized/0004/6604/46604v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.biospace.com/news_story.aspx?NewsEntityId=103582",
    "source_description": "MacroGenics, Inc. (JOBS) Acquires Raven Biotechnologies, Inc. ",
    "acquired_year": 2008,
    "acquired_month": 7,
    "acquired_day": 17,
    "company":
     {"name": "Raven Biotechnologies",
      "permalink": "raven-biotechnologies",
      "image": null}}],
 "offices":
  [{"description": "",
    "address1": "1500 East Gude Drive",
    "address2": "",
    "zip_code": "20850",
    "city": "Rockville",
    "state_code": "MD",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "MacroGenics banks $20M in potential $1.1B cancer-drugs deal with Servier",
    "stoned_year": 2012,
    "stoned_month": 9,
    "stoned_day": 20,
    "source_url": "http://www.fiercebiotech.com/story/macrogenics-banks-20m-potential-11b-cancer-drugs-deal-servier/2012-09-20?utm_source=rss\u0026utm_medium=rss",
    "source_text": "",
    "source_description": "MacroGenics banks $20M in potential $1.1B cancer-drugs deal with Servier",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "MacroGenics",
      "permalink": "macrogenics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        101],
       "assets/images/resized/0008/4254/84254v1-max-150x150.jpg"],
      [[250,
        169],
       "assets/images/resized/0008/4254/84254v1-max-250x250.jpg"],
      [[450,
        305],
       "assets/images/resized/0008/4254/84254v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}